Clincosm LogoSign in Get a demo

Alzheimer's Disease

Showing NaN - NaN of 92
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer's Disease Trial in Worldwide (TRx0237 150 mg/day, TRx0237 250 mg/day, Placebo)

Completed
  • Alzheimer's Disease
  • TRx0237 150 mg/day
  • +2 more
  • Phoenix, Arizona
  • +120 more
Mar 12, 2018

Alzheimer's Disease Trial in Worldwide (TRx0237 200 mg/day, Placebo)

Completed
  • Alzheimer's Disease
  • TRx0237 200 mg/day
  • Placebo
  • Phoenix, Arizona
  • +94 more
Mar 12, 2018

Alzheimer's Disease Trial in United States (LY451395, Placebo)

Completed
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +16 more
Oct 23, 2017

Alzheimer's Disease Trial in Worldwide (Placebo, Idalopirdine)

Completed
Has Results
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +136 more
Aug 22, 2017

Dementia, Alzheimer's Disease Trial in United States ([18F]NAV4694)

Unknown status
  • Dementia
  • Alzheimer's Disease
  • Sun City, Arizona
  • +14 more
Jul 25, 2017

Alzheimer's Disease Trial in Worldwide (MABT5102A, )

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +91 more
Jul 10, 2017

Alzheimer's Disease Trial in France, Spain, United States (MABT5102A, )

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +28 more
Jul 10, 2017

Alzheimer's Disease Trial in Worldwide (RO4602522, Placebo, Donepezil)

Completed
  • Alzheimer's Disease
  • Anaheim, California
  • +141 more
May 25, 2017

Alzheimer's Disease Trial in Worldwide (Dimebon, Placebo comparator)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +100 more
Sep 24, 2016

Alzheimer's Disease Trial in France, Italy, United States (florbetapir (18F))

Completed
Has Results
  • Alzheimer's Disease
  • florbetapir (18F)
  • Phoenix, Arizona
  • +56 more
Jul 8, 2016

Alzheimer's Disease, Dementia Trial in Worldwide (EVP-6124)

Terminated
  • Alzheimer's Disease
  • Dementia
  • Phoenix, Arizona
  • +85 more
May 2, 2016

Alzheimer's Disease, Dementia Trial in Worldwide (Drug: EVP-6124, Placebo)

Terminated
  • Alzheimer's Disease
  • Dementia
  • Drug: EVP-6124
  • Placebo
  • Phoenix, Arizona
  • +81 more
May 2, 2016

Alzheimer's Disease Trial in United States (GC021109, Placebo)

Completed
  • Alzheimer's Disease
  • Long Beach, California
  • +4 more
Feb 1, 2016

Alzheimer's Disease Trial in United States (Dimebon, Placebo)

Completed
  • Alzheimer's Disease
  • Los Alamitos, California
  • +3 more
Nov 6, 2015

Alzheimer's Disease Trial in Worldwide (BMS-708163, Placebo)

Completed
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +40 more
Sep 23, 2015

Alzheimer's Disease Trial in Worldwide (Avagacestat, Placebo)

Terminated
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +63 more
Sep 23, 2015

Alzheimer's Disease Trial in Orlando (Bexarotene, Placebo)

Completed
  • Alzheimer's Disease
  • Orlando, Florida
    Compass Research
Aug 11, 2015

Alzheimer's Disease Trial in Delray Beach, Orlando, Beachwood (BIIB037, Placebo)

Completed
  • Alzheimer's Disease
  • Delray Beach, Florida
  • +2 more
Mar 19, 2015

Alzheimer's Disease Trial in Worldwide (LY450139, Placebo)

Completed
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +90 more
Jan 28, 2015

Alzheimer's Disease Trial in United States (ACC-001 (vanutide cridificar))

Completed
  • Alzheimer's Disease
  • ACC-001 (vanutide cridificar)
  • Sun City, Arizona
  • +24 more
Dec 11, 2014

Alzheimer's Disease Trial in Worldwide (ABT-126, )

Completed
  • Alzheimer's Disease
  • Fresno, California
  • +42 more
Oct 24, 2014

Alzheimer's Disease Trial in Worldwide (semagacestat)

Completed
Has Results
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +70 more
Sep 22, 2014

Alzheimer's Disease Trial in Worldwide (BMS-241027, Placebo matching BMS-241027)

Completed
  • Alzheimer's Disease
  • Anaheim, California
  • +23 more
Jul 23, 2014

Alzheimer's Disease, CNS Diseases, Cognition Trial in Worldwide (EVP-6124, Placebo)

Completed
  • Alzheimer's Disease
  • +2 more
  • Phoenix, Arizona
  • +53 more
Mar 28, 2014

Alzheimer's Disease Trial in Austria, Canada, United States (Bapineuzumab)

Terminated
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +190 more
Nov 26, 2013